Policy field(s)

Enterprise and Industry, Internal Market, Consumer Affairs, Public Health

Target group

Any interested parties, including authorities of the Member States, manufacturers of cosmetic products, producers of the substances concerned and relevant industry and consumers associations.

Period of consultation

From 29 July to 23 October 2015.

Background

Methylisothiazolinone (MI) background information

Proposed modifications to Annex V of the Cosmetics Regulation

Modifications suggested by the Commission

Request

The Commission would like to invite any interested parties, including authorities of Member States, manufacturers of cosmetic products, producers of the substances concerned and relevant industry and consumers associations, to submit their comments on the proposed measures and on their possible economic impact.

With relation to the economic impact, the information/comments should refer, inter alia, to the following topics:

• feasibility of the proposed changes;
• competitiveness, markets and trade;
• direct and indirect costs imposed on business, including SMEs;
• innovation and research;
• specific regions, sectors or workers;
• third countries and international relations;
• macroeconomic environment.

How to submit your contribution

Any comments should be sent with the reference 'Methylisothiazolinone - Public Consultation' by post or e-mail by 23 October 2015 at the latest to:

European Commission
Directorate General Internal Market, Industry, Entrepreneurship and SMEs
Unit D/4, Health Technology and Cosmetics,
Av. d’Auderghem 45, BREY 12/10
1040 Brussels
Belgium

E-mail: GROW-COSMETICS-AND-MEDICAL-DEVICES@ec.europa.eu

Translations

The consultation is available in all languages.

Results of the consultation

A total of 14 responses were received from citizens, consumer associations, national authorities, academia, and industry.

This summary report provides a collection of their views and contributions regarding the public consultation on the use of Methylisothiazolinone as a preservative in cosmetic products. We would like to thank all respondents who provided input.  This report does not in any way reflect the views and position of the European Commission and therefore does not bind the Commission in acting accordingly.

Next steps

From the feedback received, the Commission services will decide on the follow-up, which may take the form of a proposal for an amendment to Annex V of the Cosmetics Regulation thereby banning the use of Methylisothiazolinone as a preservative in leave-on cosmetic products.

Protection of Personal data

Specific Privacy Statement

Protection of personal data